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Recently developed techniques of culturing human tissues
permit the in vitro recovery of progenitor cells and the study
of factors that regulate the growth of these cells. We applied
this technique to benign and malignant breast tissues to
determine how their ability to grow in agar changes as
transformation occurs and as tumours progress. We also
measured the responsiveness of the clonogenic cells from
these tissues to a combination of four growth factors. We
found that there was a continuing progression of increasing
proliferation in agar from benign through primary
carcinoma to metastases. We also found that the clonogenic
cells of tissues from all stages retained their responsiveness to
the tested growth factors and that the degree of their
hormonal responsiveness remained similar to that of the
parent tissue.
In common with their parent tissues, tumours are
composed of stem cells and of their progenitor cells. Unlike
the parent tissues, however, the proliferative activity of
tumour progenitor cells is regulated by growth factors
unique to tumours (Todaro et al., 1980; Dickson et al.,
1986). A contributory role of the growth regulators of the
parent tissue is not certain. Techniques to recover the
clonogenic tumour cell populations (the in vitro counterparts
of stem cell progenitors) have recently been developed
(Hamburger & Salmon, 1977a, b; Courtenay et al., 1978;
Kinball et al., 1978). Since the culturing of these cells
provides a tool to study tissue growth regulation, we used
the technique to define the colony forming ability and the
proliferative response to some selected hormones, of benign
and malignant breast tissues.
Normal breast tissue was obtained from 9 women, 7 of
whom underwent a reduction mammoplasty and 2 a
modified radical mastectomy. Four of these women had in
the past been treated for stages I or II breast carcinoma. The
remaining 5 women underwent reduction mammoplasty for
cosmetic reasons. Malignant breast tissue was obtained from
21 patients with primary breast carcinoma and from 63
patients with metastatic breast carcinoma (33 solid tumour
tissues, and 30 malignant effusions).
Oestrogen receptors (ER) were measured by the dextran-
coated charcoal method. Values for .10 fmolmg1 protein
were considered positive, and values <10fmolmg 1 protein
were considered negative. Forty-one tumours (9 primary and
32 metastatic) were ER positive, and 35 tumours (12 primary
and 23 metastatic) were ER negative.
Solid tissues were collected in 50ml culture medium and
sliced into 1 mm cubes. Effusions were centrifuged at 40g for
10min, and cells resuspended in Ham's F12 medium (F12;
GIBCO, Grand Island, NY), supplemented with 10% heat-
inactivated foetal bovine serum (FBS; KC Biological,
Lenexa, KS). Cell aggregates were then incubated in a
mixture of 1.0% Worthington type III collagenase
(Worthington Biochemical Corporation, Freehold, NJ),
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0.6% elastase and 0.005% deoxyribonuclease (Sigma
Chemical Co., St. Louis, MO), at 370C for 4-16h, under
continuous agitation. Thereafter, cells were washed in
calcium- and magnesium-free Hank's balanced salt solution
(GIBCO) and resuspended in F12 with 10% FBS.
Remaining aggregates of cells were removed by passing the
suspension sequentially through 18-, 22-, and 25-gauge
needles. A Coulter counter (Coulter Electronics, Hialeah,
FL) was used, and the viability of cells was determined by
their ability to exclude trypan blue dye.
Cells were set into agar cultures, as described previously
(Hug et al., 1984). Upper layers consisted of a mixture of a-
minimal essential medium (GIBCO, Grand Island, NY) and
15% FBS, in 0.3% agar (Bactoagar Difco, American
Scientific Products, Houston, TX). Cells (5 x 105) were added
to each 1 ml volume of this mixture. Underlayers consisted
of 90% F12 and 10% horse serum (KC Biological, Lenexa,
KS) in 0.5% agar. Oestradiol (5 xl0- M 17-fl-), lOpgml -
insulin, 50ngml-1 epidermal growth factor, and 2.5,ugml 1
hydrocortisone were supplemented to the underlayers of half
of the cultures. (Each hormone was used at the dose that
had maximally stimulated the clonogenic growth of 4 breast
tumour cell lines (Hug et al., 1984).) Cultures were set up in
triplicate. One plate of each specimen was fixed with
glutaraldehyde and stored at 40 C. Cultures were incubated
at 370C in a humidified atmosphere of 5% CO2 and 12%
02 for 14 days. Cultures were then examined with an
inverted phase microscope for clonogenic growth. Aggregates
of 50 or more cells, or aggregates of a minimal diameter of
.75pm and of uniform morphology, were considered to
represent the progeny of clonogenic cells and were counted
as colonies. The glutaraldehyde fixed plates were scored
using the identical criteria, and the number of clumps that
had contaminated the cultures were so enumerated and
subtracted from the score of the cultured plates to arrive at
the final colony count. The morphology of some cultured
cells was also studied. Nucleolar antigens were present in all
cells examined, and mucin was secreted by some. Colonies of
some cultures were also transferred into tissue culture flasks,
and continued outgrowth at the colony margins could at
times be observed.
Clonogenicity of tumours was defined as the percentage of
cells seeded that formed colonies. The hormone sensitivity of
tumours was calculated as the ratio of colonies formed under
hormone-supplemented and regular conditions, and was
expressed at the loglo basis. For the analysis, tumours were
grouped according to the disease stage as normal breast
tissues (Group A), primary tumours (Group B), metastatic
ER-positive tumours (Group C), metastatic ER-negative and
ER-unknown tumours (Group D). Tumours that formed less
than 1 colony under regular conditions were not included in
our evaluation. The one-way analysis of variance with the
Student-Newman Keuls multiple range test was applied to
compare the clonogenic growth of tissues from the 4 groups
and to compare the hormonal responsiveness of the 4 classes
of tissues.
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The mean viability of cells set into culture was 91 (±8)%
for all tissues of origin. There was a continuing progression
of increasing clonogenicity from benign tissue through
primary carcinoma to metastasis. The median number of
colonies formed per 105 cells was: 4(2-19) for benign tissues,
35 (1-658) for primary carcinomas and, 74 (2-1037) for
metastatic carcinoma; the respective mean values were 7+7,
90±+162, 125±+158.
Oestradiol (17-fl-), epidermal growth factor, insulin and
hydrocortisone in combination were used to measure the
sensitivity of cells to regular growth factors and hormones.
The combined hormones increased the clonogenic cell
fraction of 85 of the 92 breast tissues (92%). An increase of
the clonogenic cell fraction was observed in all benign
tissues, in 76% of primary tumours, and 97% of metastatic
tumours. The hormones increased the clonogenicity of
normal bone marrow 1.3-fold. In contrast, the hormone-
induced growth increment of breast tissues was 3.4-fold on
average. The growth increment was similar for all groups of
tissues, but was 4.4-fold for the metastatic ER-positive
tumours. The enhanced proliferative response to hormones
of ER-positive tumours was, however, not statistically
significant at the 0.05 level. The hormonal sensitivity of
clonogenic cells from benign and malignant tissues is
summarized in Table I and illustrated in Figure 1.
Clonogenic growth of normal breast tissue in agar culture
was scant. The ability of cells to form colonies developed
Table I Proliferative response to hormones of normal bone
marrows and breast tissues
Hormone sensitivitya
No. of Mean values Median values
Origin oftissue specimens +s.d. (range)
Normal bone marrows 6 0.10+0.07 0.07 (0.05-0.11)
Normal breast tissues 9 0.70+0.24 0.73 (0.30-0.95)
Metastatic tumours 63 0.57+0.62 0.35 (0.49-2.79)
aCalculated as defined in the text.
after tissue transformation had occurred and increased
further as tumours progressed from the early to the
advanced stages. Since anchorage-independent growth is a
criterion of transformed tissues, and clonogenicity of
tumours is associated with tumour formation in mice (Shin
et al., 1979) and with survival of patients (Hug et al., 1985),
our findings are not novel. The findings support, however,
the validity of the tool used to investigate some growth-
regulatory mechanisms of breast tumours.
Oestradiol (17-fl-), insulin, hydrocortisone, and epidermal
growth factor, are among the factors and hormones that are
operative in the development and growth of the mammary
gland. These factors, in combination, increased the
proliferative activity of all benign breast tissues, and to our
surprise also of 99% of malignant breast tissues. Thus, the
responsiveness of cells to these regular growth factors
persisted after tissue transformation had occurred, and
remained unchanged for the responsive proportion of
clonogenic cells as tumours progressed from the primary to
the metastatic stage. The responsiveness of the metastatic
tumours that contained cytoplasmic receptors for oestrogens
was even higher than that of normal breast tissues, albeit not
at a statistically significant level.
We conclude that two distinctive biological properties of
breast tissue cells can be measured in vitro: firstly, the ability
of cells to form colonies in agar cultures, and secondly, the
responsiveness of these clonogenic cells to factors that can
regulate their proliferative activity. We found that the clono-
genicity of tissues increased with the formation of tumours
and with the progression of tumours to the more advanced
stages, while the responsiveness of clonogenic cells to some
of the hormones that regulate the development of the parent
organ tissue persisted for a large proportion of tumours.
Although autocrine and paracrine growth factors are often
considered more important growth regulators of tumours
(Rozengurt, 1983; Todaro et al., 1980; Sirbasku, 1978; Sporn
& Todaro, 1980), our findings suggest that the normal
growth-regulatory pathways often remain functional
following transformation. Further studies will be necessary
to define the relative roles in tumour growth regulation of
RESPONSIVENESS OF NORMAL AND MALIGNANT BREAST TISSUES TO THE
r-
+
U)
0
U
0
._
E
C
0 IL)
0
-
CJ
J
3.6
2.8
2.0
1.2
0.4
GROWTH-STIMULATORY HORMONES
(A) (B) (C)
Normal Primary Metastatic Brea
Breasts Breast Tumours ER-Positive E
0
S
0
0
0
I
0
0
0
0
0
S
00
0
0
(D)
ast Tumours
ER-Negative
I
4
-t
0
0
0
Figure 1 The cellular sensitivity to the combination of 17-f-oestradiol, epidermal growth factor, insulin, and hydrocortisone was
tested. Colony formation is expressed on a log1o basis. Clonogenic growth of: A, normal benign tissues; B, primary breast
tumours; C, metastatic ER-positive tumours; and D, metastatic ER-negative or ER-unknown tumours. Dots within the blank bars
represent colony formation under regular conditions, and dots within the hatched bars, colony formation under the hormone-
enriched conditions. Each dot represents the mean value of triplicate cultures. The coefficient of variation of replicate cultures
ranged between 0.01 to 0.75, median 0.15. Bars indicate the means of each class of tissues. The differences in hormone-mediated
growth enhancement were not statistically significant for any ofthe 4 groups of tissues.
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regular and tumour-specific growth factors, and to define if
these factors act independently or in concert. It is of note,
however, that in a small sample of patients the response to
endocrine treatment was associated with the in vitro
responsiveness of their tumour to these regular hormones
(Hug et al., 1985; Ro et al., 1985).
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